S

Shanghai Henlius Biotech Inc
HKEX:2696

Watchlist Manager
Shanghai Henlius Biotech Inc
HKEX:2696
Watchlist
Price: 23.9 HKD 0.21%
Market Cap: 13B HKD
Have any thoughts about
Shanghai Henlius Biotech Inc?
Write Note

Wall Street
Price Targets

Price Targets Summary
Shanghai Henlius Biotech Inc

Wall Street analysts forecast Shanghai Henlius Biotech Inc stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shanghai Henlius Biotech Inc is 22.91 HKD with a low forecast of 20.53 HKD and a high forecast of 25.83 HKD.

Lowest
Price Target
20.53 HKD
14% Downside
Average
Price Target
22.91 HKD
4% Downside
Highest
Price Target
25.83 HKD
8% Upside
Shanghai Henlius Biotech Inc Competitors:
Price Targets
7774
Japan Tissue Engineering Co Ltd
172% Upside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
30% Upside
BVXP
Bioventix PLC
56% Upside
ALGEN
Genoway SA
76% Upside
BCYC
Bicycle Therapeutics PLC
164% Upside
ALGS
Aligos Therapeutics Inc
73% Upside
4893
Noile-Immune Biotech Inc
181% Upside
CMRX
Chimerix Inc
139% Upside

Revenue
Forecast

Revenue Estimate
Shanghai Henlius Biotech Inc

For the last 5 years the compound annual growth rate for Shanghai Henlius Biotech Inc's revenue is 274%. The projected CAGR for the next 4 years is 12%.

274%
Past Growth
12%
Estimated Growth
Estimates Accuracy
7%
Average Beat

Operating Income
Forecast

Operating Income Estimate
Shanghai Henlius Biotech Inc

The compound annual growth rate of Shanghai Henlius Biotech Inc's operating income for the next 4 years is 20%.

N/A
Past Growth
20%
Estimated Growth
Estimates Accuracy
46%
Average Beat

Net Income
Forecast

Net Income Estimate
Shanghai Henlius Biotech Inc

The compound annual growth rate of Shanghai Henlius Biotech Inc's net income for the next 3 years is 24%.

N/A
Past Growth
24%
Estimated Growth
Estimates Accuracy
40%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shanghai Henlius Biotech Inc's stock price target?
Price Target
22.91 HKD

According to Wall Street analysts, the average 1-year price target for Shanghai Henlius Biotech Inc is 22.91 HKD with a low forecast of 20.53 HKD and a high forecast of 25.83 HKD.

What is Shanghai Henlius Biotech Inc's Revenue forecast?
Projected CAGR
12%

For the last 5 years the compound annual growth rate for Shanghai Henlius Biotech Inc's revenue is 274%. The projected CAGR for the next 4 years is 12%.

What is Shanghai Henlius Biotech Inc's Operating Income forecast?
Projected CAGR
20%

The compound annual growth rate of Shanghai Henlius Biotech Inc's operating income for the next 4 years is 20%.

What is Shanghai Henlius Biotech Inc's Net Income forecast?
Projected CAGR
24%

The compound annual growth rate of Shanghai Henlius Biotech Inc's net income for the next 3 years is 24%.

Back to Top